Zevenbergen Capital Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $35.7M | Sell |
|
|||||
|
2020
Q2 | $81.6M | Buy |
|
|||||
|
2020
Q1 | $54.3M | Buy |
|
|||||
|
2019
Q4 | $52M | Buy |
|
|||||
|
2019
Q3 | $39.8M | Sell |
|
|||||
|
2019
Q2 | $54.7M | Buy |
|
|||||
|
2019
Q1 | $42M | Buy |
|
|||||
|
2018
Q4 | $36.2M | Buy |
|
|||||
|
2018
Q3 | $37.6M | Sell |
|
|||||
|
2018
Q2 | $37.5M | Buy |
|
|||||
|
2018
Q1 | $21.5M | Hold |
|
|||||
|
2017
Q4 | $23.6M | Sell |
|
|||||
|
2017
Q3 | $24.9M | Sell |
|
|||||
|
2017
Q2 | $25.8M | Sell |
|
|||||
|
2017
Q1 | $27.2M | Sell |
|
|||||
|
2016
Q4 | $28.9M | Sell |
|
|||||
|
2016
Q3 | $37.9M | Sell |
|
|||||
|
2016
Q2 | $35.5M | Sell |
|
|||||
|
2016
Q1 | $38M | Buy |
|
|||||
|
2015
Q4 | $48M | Buy |
|
|||||
|
2015
Q3 | $43.6M | Sell |
|
|||||
|
2015
Q2 | $56.9M | Buy |
|
|||||
|
2015
Q1 | $46.1M | Buy |
|
|||||
|
2014
Q4 | $2.18M | Buy |
|